| User's Publication |
|
20496
Ishikura N, Sugimoto M, Yorozu K, Kurasawa M, Kondoh O.
Anti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1low and immune desert‑like mouse tumors.
Oncol Rep
2022
47(2)
PubMed ID: 34958105
|
|
16437
Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, Takamatsu S, Mise Y, Ukita M, Taki M, Yamanoi K, Horikawa N, Abiko K, Yamaguchi K, Baba T, Matsumura N, Mandai M.
B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
Cancer Immunol Res
2022
10(1):56-69.
PubMed ID: 34799346
|
|
20694
Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, Suzuki H, Hosoe Y, Furutake Y, Taki M, Abiko K, Yamaguchi K, Nakai H, Baba T, Matsumura N, Yoshizawa A, Ueno H, Mandai M.
CXCL13-producing CD4+ T cells accumulate in early phase of tertiary lymphoid structures in ovarian cancer.
JCI Insight
2022
PubMed ID: 35552285
|
|
14343
Goto S, Sakoda Y, Adachi K, Sekido Y, Yano S, Eto M, Tamada K.
Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models
Cancer Immunol Immunother
2021
PubMed ID: 33559069
|
|
20242
Mori T, Hazekawa M, Yoshida M, Nishinakagawa T, Uchida T, Ishibashi D.
Enhancing the anticancer efficacy of a LL-37 peptide fragment analog using peptide-linked PLGA conjugate micelles in tumor cells.
Int J Pharm
2021
120891
PubMed ID: 34324984
|
|
9914
Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Tsukasa Baba, Junzo Hamanishi, Ken Yamaguchi, Ryusuke Murakami, Mana Taki, Masayo Ukita, Yuko Hosoe, Masafumi Koshiyama, Ikuo Konishi, Masaki Mandai
Anti-VEGF Therapy Resistance in Ovarian Cancer Is Caused by GM-CSF-induced Myeloid-Derived Suppressor Cell Recruitment
Br J Cancer
2020
122(6):778-788
PubMed ID: 31932754
|
|
13079
Komura N, Mabuchi S, Shimura K, Yokoi E, Kozasa K, Kuroda H, Takahashi R, Sasano T, Kawano M, Matsumoto Y, Kodama M, Hashimoto K, Sawada K, Kimura T.
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
Cancer Immunol Immunother
2020
PubMed ID: 32561967
|
|
13158
Yang M, Zhang G, Wang Y, He M, Xu Q, Lu J, Liu H, Xu C.
Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer.
Br J Cancer
2020
PubMed ID: 32778818
|
|
13282
Han N, Anwar D, Hama N, Kobayashi T, Suzuki H, Takahashi H, Wada H, Otsuka R, Baghdadi M, Seino KI.
Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells.
Inflamm Regen
2020
PubMed ID: 33072227
|
|
11603
Aoki N, Matsui Y.
Comprehensive Analysis of Mouse Cancer/Testis Antigen Functions in Cancer Cells and Roles of TEKT5 in Cancer Cells and Testicular Germ Cells.
Mol. Cell. Biol.
2019
PubMed ID: 31208979
|
|
6962
Hazekawa M, Nishinakagawa T, Kawakubo-Yasukochi T, Nakashima M.
Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination model.
J Pharmacol Sci
2019
139(3):231-239
PubMed ID: 30803892
|
|
10833
Taki M, Abiko K, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Yamanoi K, Horikawa N, Hosoe Y, Nakamura E, Sugiyama A, Mandai M, Konishi I, Matsumura N.
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.
Nat Commun
2018
9:1685
PubMed ID: 29703902
|
|
14925
Nakagawa S, Serada S, Kakubari R, Hiramatsu K, Sugase T, Matsuzaki S, Matsuzaki S, Ueda Y, Yoshino K, Ohkawara T, Fujimoto M, Kishimoto T, Kimura T, Naka T.
Intratumoral Delivery of an Adenoviral Vector Carrying the SOCS-1 Gene Enhances T-Cell-Mediated Antitumor Immunity By Suppressing PD-L1
Mol Cancer Ther
2018
17(9):1941-1950.
PubMed ID: 29891489
|
|
14927
Taha AAA, Koshiyama M, Matsumura N, Abiko K, Yamaguchi K, Hamanishi J, Baba T, Kharma B, Mohamed IH, Ameen MM, Ismail SA, Konishi I, Mandai M.
The effect of the type of dietary protein on the development of ovarian cancer
Oncotarget
2018
9(35):23987-23999
PubMed ID: 29844867
|
|
14348
Horikawa N, Abiko K, Matsumura N, Hamanishi J, Baba T, Yamaguchi K, Yoshioka Y, Koshiyama M, Konishi I.
Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
Clin Cancer Res
2017
23(2):587-599
PubMed ID: 27401249
|
|
7149
Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, Konishi I, Mandai M.
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.
Cancer Res.
2015
75:5034-45
PubMed ID: 26573793
|
|
7194
Kobayashi A, Tanizaki Y, Kimura A, Ishida Y, Nosaka M, Toujima S, Kuninaka Y, Minami S, Ino K, Kondo T.
AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer.
Eur. J. Pharmacol.
2015
766:63-75
PubMed ID: 26410360
|
|
15068
Abiko K, Matsumura N, Hamanishi J, Horikawa N, Murakami R, Yamaguchi K, Yoshioka Y, Baba T, Konishi I, Mandai M.
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
Br J Cancer
2015
112(9):1501-9
PubMed ID: 25867264
|
|
9104
Fumi Goshima, Shinichi Esaki, Chenhong Luo, Maki Kamakura, Hiroshi Kimura, Yukihiro Nishiyama
Oncolytic Viral Therapy With a Combination of HF10, a Herpes Simplex Virus Type 1 Variant and Granulocyte-Macrophage Colony-Stimulating Factor for Murine Ovarian Cancer
Int J Cancer
2014
134 (12), 2865-77
PubMed ID: 24265099
|
|
14926
Tanizaki Y, Kobayashi A, Toujima S, Shiro M, Mizoguchi M, Mabuchi Y, Yagi S, Minami S, Takikawa O, Ino K.
Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment
Cancer Sci
2014
105(8):966-73
PubMed ID: 24826982
|
Back
Top
CELL BANK Website
